We resume the series about the scientific achievements by our INVITE fellows continues with Mathieu Repellin, who has been working on nanomedicine solutions to treat Myotonic Dystrophy type 1 .
We resume the series about the scientific achievements by our INVITE fellows continues with Mathieu Repellin, who has been working on nanomedicine solutions to treat Myotonic Dystrophy type 1 .
After 3 years of PhD thesis under the INVITE program proposed within the European Union’s Horizon 2020, I’m glad to make a summary of this enriching experience. The INVITE program offered to all our 14 PhD candidates of different scientific disciplines a unique experience with multidisciplinary and international approach. The meta-disciplinary training and research programme proposed to each of the PhD candidates offered a real...
Read More